This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanellakopoulou, K.
Right arrow Articles by Giamarellou, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanellakopoulou, K.
Right arrow Articles by Giamarellou, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 1999, p. 714-716, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Lactic Acid Polymers as Biodegradable Carriers of Fluoroquinolones: An In Vitro Study

Kyriaki Kanellakopoulou,1 Maria Kolia,2 Antonios Anastassiadis,3 Themistoklis Korakis,3 Evangelos J. Giamarellos-Bourboulis,2 Andreas Andreopoulos,4 Eleftherios Dounis,3 and Helen Giamarellou1,*

Fourth Department of Internal Medicine, Athens Medical School, Sismanoglion General Hospital,1 First Department of Propedeutic Medicine, Athens Medical School,2 and Department of Orthopaedics,3 Laiko General Hospital, and Department of Chemical Engineering, Athens Polytechnique School,4 Athens, Greece

Received 5 May 1998/Returned for modification 3 November 1998/Accepted 26 December 1998

A biodegradable polymer of DL-dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.

* Corresponding author. Mailing address: Fourth Department of Internal Medicine, Sismanoglion General Hospital, Athens 151 26, Greece. Phone: (301) 80 39 542. Fax: (301) 80 39 543.

Antimicrobial Agents and Chemotherapy, March 1999, p. 714-716, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kanellakopoulou, K., Thivaios, G. C., Kolia, M., Dontas, I., Nakopoulou, L., Dounis, E., Giamarellos-Bourboulis, E. J., Andreopoulos, A., Karagiannakos, P., Giamarellou, H. (2008). Local Treatment of Experimental Pseudomonas aeruginosa Osteomyelitis with a Biodegradable Dilactide Polymer Releasing Ciprofloxacin. Antimicrob. Agents Chemother. 52: 2335-2339 [Abstract] [Full Text]  
  • Koort, J. K., Makinen, T. J., Suokas, E., Veiranto, M., Jalava, J., Knuuti, J., Tormala, P., Aro, H. T. (2005). Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due to Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 1502-1508 [Abstract] [Full Text]  
  • Kanellakopoulou, K., Galanakis, N., Giamarellos-Bourboulis, E. J., Rifiotis, C., Papakostas, K., Andreopoulos, A., Dounis, E., Karagianakos, P., Giamarellou, H. (2000). Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. J Antimicrob Chemother 46: 311-314 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»